Want to join the conversation?
$VRSK said its 4Q15 adjusted EBITDA rose 22.5% and adjusted EBITDA margin was 46.9% versus 46.2% in 4Q14. Free cash flow grew 33.5% to $458MM and CapEx rose 13.2% to $166MM in FY15. Company repurchased 279,000 shares in 4Q15 at an average price of $73.20 or $20MM in total. At Dec. 31, $VRSK had $469MM remaining under its repurchase authorization.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?